| Genomic Medicine |
1 |
1 |
| Multiple Sclerosis |
0 |
0.92 |
| Biologic Therapy |
0 |
0.58 |
| Progressive Multifocal Leukoencephalopathy |
0 |
0.99 |
| Genetics |
0 |
0.97 |
| Leukoencephalopathy |
0 |
0.98 |
| Breast Cancer |
0 |
0.35 |
| Antineoplastic Drug |
0 |
0.29 |
| Toxicology |
0 |
0.28 |
| Cancer Risk |
0 |
0.26 |
| Brain |
0 |
0.24 |
| Cancer |
0 |
0.24 |
| JC Virus |
0 |
0.24 |
| Lymphocytes |
0 |
0.24 |
| Monoclonal Antibody |
0 |
0.24 |
| Hodgkin Lymphoma |
0 |
0.19 |
| Autoimmune Disease |
0 |
0.12 |
| Breast |
0 |
0.12 |
| Central Nervous System |
0 |
0.12 |
| Corticosteroids |
0 |
0.12 |
| Demyelination |
0 |
0.12 |
| Europe |
0 |
0.12 |
| Immunosuppressive Therapy |
0 |
0.12 |
| Interferon Beta |
0 |
0.12 |
| Lymphoma |
0 |
0.12 |
| Polyomavirus |
0 |
0.12 |
| Preventive Screening |
0 |
0.12 |
| Serology |
0 |
0.12 |
| Stevens-Johnson Syndrome |
0 |
0.12 |
| Toxic Epidermal Necrolysis |
0 |
0.12 |
| UK Site Content |
0 |
0.12 |